SCHEMBL7205946

SCHEMBL7205946

NC(=O)N1CCC(S(=O)(=O)c2ccc(Oc3ccccn3)cc2)C(O)(C(=O)O)C1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MMP1 P03956 5/20 0.39
MMP13 P45452 5/20 0.39
MMP2 P08253 3/20 0.39
MMP9 P14780 3/20 0.39
MGLL Q99685 1/20 0.37
BTK Q06187 2/20 0.37
MMP3 P08254 2/20 0.36
MMP14 P50281 2/20 0.36
HRH3 Q9Y5N1 1/20 0.36
MMP12 P39900 1/20 0.36
S1PR2 O95136 1/20 0.35
ADAMTS4 O75173 1/20 0.35
LTA4H P09960 1/20 0.35
PTGS2 P35354 1/20 0.35
SCN7A Q01118 2/20 0.35
KCNH2 Q12809 2/20 0.35
HTT P42858 1/20 0.34
ALDH1A1 P00352 1/20 0.34
LMNA P02545 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7207163 0.88 MMP1 (0.45) MMP1MMP13MMP2MMP9MMP3
SCHEMBL7203051 0.85 MMP1 (0.39) MMP1MMP13MMP2MMP9MMP3
SCHEMBL7201292 0.85 PARP10 (0.44) MMP1MMP13MMP14ADAMTS4ALDH1A1
SCHEMBL7202625 0.85 CCR6 (0.39) MMP1MMP13MMP9
SCHEMBL7204248 0.83 MMP1 (0.42) MMP1MMP13MMP2MMP9BTK
SCHEMBL7206530 0.83 TSHR (0.45) MMP1MMP13MMP2MMP9MMP3
SCHEMBL7199692 0.82 PARP10 (0.41) MMP1MMP13MMP2MMP9MMP3
SCHEMBL7203058 0.82 MMP9 (0.47) MMP1MMP13MMP2MMP9MMP3
SCHEMBL7204562 0.82 MMP13 (0.51) MMP1MMP13MMP2MMP9MMP3
SCHEMBL7204544 0.82 MMP1 (0.41) MMP1MMP13MMP2MMP9MGLL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6608104-B2 Antiarthritic agents; anticancer agents PFIZER INC 2003-08-19 US disclosed
EP-1138680-A1 Gem substituted sulfonyl hydroxamic acids as MMP inhibitors Pfizer Products Inc. (US) 2001-10-04 EP disclosed